论文部分内容阅读
目的:探讨米非司酮治疗异位妊娠的疗效,安全性及对患者生育的影响。方法:选取符合保守治疗条件患者31例,观察米非司酮治疗异位妊娠过程中的临床症状,各项试验室指标的变化;出现不良反应的几率及严重程度;治疗后输卵管的通畅情况,以判断是否对患者生育造成影响。结果:治疗成功率为87.09%;不良反应出现率为19.35%,均为轻度不适;成功病例中未育患者输卵管通畅率为100%。结论:米非司酮是一种治疗异位妊娠的高效药物,具有安全性高,不良反应少,对生育无影响的优点。
Objective: To investigate the efficacy and safety of mifepristone in the treatment of ectopic pregnancy and the impact on the patient’s reproduction. Methods: 31 patients with conservative treatment were selected to observe the clinical symptoms of mifepristone in the treatment of ectopic pregnancy, the changes of various laboratory indicators; the incidence and severity of adverse reactions; tubal patency after treatment, To determine whether the patient’s reproductive impact. Results: The success rate of treatment was 87.09%; the incidence of adverse reactions was 19.35%, all of which were mild discomfort; tubal patency rate was 100% in non-fertile patients in successful cases. Conclusion: Mifepristone is an effective drug for the treatment of ectopic pregnancy, with the advantages of high safety, less adverse reactions and no effect on reproduction.